Neovacs (ALNEV) | Stock Price History & Returns | 2010 - 2026

How has Neovacs (ALNEV) stock performed during last 12 months?

Over the last 12 months, Neovacs has delivered a total return of -100.0%.

• 52-Week High reached EUR4.20 on N/A.
• 52-Week Low touched EUR0.00 on N/A.
• Current Price trading at EUR0.00 as of June 4, 2026.

What is Neovacs's (ALNEV) total stock return over the past 5 years?

Over the past 5 years, investing EUR10,000.00 in Neovacs (alnev) would have grown to approximately EUR0.00 as of June 4, 2026, representing a total return of -100.0%.

This represents a compound annual growth rate (CAGR) of -100.0% over the 5-year period.

How does Neovacs's Stock 10-year annualized return compare to the Healthcare sector?

Neovacs (alnev) has delivered an annualized return of -100.0% over the past 10 years.

To illustrate: EUR10,000.00 invested in Neovacs would have grown to EUR0.00 over this 10-year period.

This performance should be compared against other companies in the Healthcare sector to understand relative performance.

What was Neovacs's best-performing year historically?

Neovacs (alnev) has achieved its strongest performance over the 12 months period, delivering a total return of -100.0%.

What is the longest period of consecutive yearly growth Neovacs has achieved historically?

Neovacs (alnev) shows the following performance across different time periods:

Negative Returns: 12 months (-100.0%), 3 years (-100.0%), 5 years (-100.0%), 10 years (-100.0%)

This represents mixed performance in delivering positive returns across different time horizons.

For more common questions about our data, please visit our About Data page.